Recurrent Pregnancy Loss and Thrombophilia (original) (raw)

Abstract

Emerging data seem to be available also on the role of active thromboprophylaxis with heparin and pregnancy outcome. In the last decades we found many data concerning the association between a hypercoagulable state and its causes and adverse pregnancy outcome, in particular recurrent pregnancy loss (RPL). First studies which focused on the association between thrombophilia and RPL underlined the role of reduced clotting inhibitors and RPL, and subsequent studies underlined a pathogenetic role of gene variant associated to hypercoagulable state in the occurrence of RPL. On the other hand, acquired thrombophilic abnormalities as antiphipsholipid syndrome are a well known cause of RPL and should be considered for a screening. These data are relevant because recent studies suggested a role of an extensive thromprophilaxis in women with RPL that should be addressed only in case of known thrombophilia and high risk of venous thromboembolism.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (57)

  1. Sarig G, Younis JS, Hoffman R, Lanir N, Blumenfeld Z, Brenner B. Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil Steril 2002;77(2):342-347.
  2. Eldor A. Thrombophilia, thrombosis and pregnancy. Thromb Haemost 2001;86(1):104-111.
  3. Carp H, Salomon O, Seidman D, Dardik R, Rosenberg N, Inbal A. Prevalence of genetic markers for throm- bophilia in recurrent pregnancy loss. Hum Reprod 2002;17(6):1633-1637.
  4. Prandoni P, Tormene D, Simioni P, Girolami A. Venous thromboembolism, fetal loss and preeclampsia in preg- nant women with congenital thrombophilia. Clin Lab 2001;47(3-4):155-159.
  5. Di Micco P, D'Uva M, Strina I, De Placido G, Di Fiore R, Quaranta S, Castaldo G. Recurrent pregnancy loss and thrombophilia. Clin Lab 2007;53(5-6):309-314.
  6. Abbate R, Lenti M, Fatini C, Gazzini A, Lapini I, Fedi S. L'ipercoagulabilità gravidica e puerperale. Haemato- logica 2003;88 (Suppl.7):1-2 [Italian]
  7. Hathaway WE and Goodnight SH Jr. Thrombosis in pregnancy. In: Disorders of hemostasis and thrombosis. A clinical guide (Eds.) Hathaway WE, Goodnight HS Jr. New York: McGraw-Hill; 1993:430-6
  8. de Boer K, ten Cate JW, Sturk A, Borm JJ, Treffers PE. Enhanced thrombin generation in normal and hyperten- sive pregnancy. Am J Obstet Gynecol 1989;160(1):95- 100.
  9. Colman-Brochu S. Deep vein thrombosis in pregnancy. MCN Am J Matern Child Nurs 2004;29(3):186-192.
  10. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, Walker ID, et al. Thrombophilia in pregnan- cy: a systematic review. Br J Haematol 2006;132(2):171- 196.
  11. Brenner B, Sarig G, Weiner Z, Younis J, Blumenfeld Z, Lanir N. Thrombophilic polymorphisms are common in women with fetal loss without apparent cause. Thromb Haemost 1999;82(1):6-9.
  12. D'Uva M, Di Micco P, Strina I, Ranieri A, Alviggi C, Mollo A, Fabozzi F, et al. Etiology of hypercoagu- lable state in women with recurrent fetal loss without other causes of miscarriage from Southern Italy: new clinical target for antithrombotic therapy. Biologics 2008;2(4):897-902.
  13. Martinelli I. Risk factors in venous thromboembolism. Thromb Haemost 2001;86(1):395-403.
  14. Franchini M, Veneri D. Inherited thrombophilia: an up- date. Clin Lab 2005;51(7-8):357-365.
  15. Pickering W, Marriott K, Regan L. G20210A prothrom- bin gene mutation: prevalence in a recurrent miscarriage population. Clin Appl Thromb Hemost 2001;7(1):25-28.
  16. Pihusch R, Buchholz T, Lohse P, Rubsamen H, Rogen- hofer N, Hasbargen U, Hiller E, et al. Thrombophilic gene mutations and recurrent spontaneous abortion: pro- thrombin mutation increases the risk in the first trimes- ter. Am J Reprod Immunol 2001;46(2):124-131.
  17. Finan RR, Tamim H, Ameen G, Sharida HE, Rashid M, Almawi WY. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population. Am J Hematol 2002;71(4):300-305.
  18. Reznikoff-Etievan MF, Cayol V, Carbonne B, Robert A, Coulet F, Milliez J. Factor V Leiden and G20210A pro- thrombin mutations are risk factors for very early recur- rent miscarriage. BJOG 2001;108(12):1251-1254.
  19. Martinelli I, Taioli E, Cetin I, Marinoni A, Gerosa S, Villa MV, Bozzo M, et al. Mutations in coagulation fac- tors in women with unexplained late fetal loss. N Engl J Med 2000;343(14):1015-1018.
  20. Rai R, Shlebak A, Cohen H, Backos M, Holmes Z, Mar- riott K, Regan L. Factor V Leiden and acquired activated J Clin Med Res • 2010;2(1):18-22
  21. D'Uva et al Articles © The authors, Journal compilation © J Clin Med Res and Elmer Press™, www.jocmr.org protein C resistance among 1000 women with recurrent miscarriage. Hum Reprod 2001;16(5):961-965.
  22. Grandone E, Margaglione M, Colaizzo D, d'Addedda M, Cappucci G, Vecchione G, Scianname N, et al. Factor V Leiden is associated with repeated and recurrent unex- plained fetal losses. Thromb Haemost 1997;77(5):822- 824.
  23. Hatzis T, Cardamakis E, Drivalas E, Makatsoris K, Bevan D, Pantos C, Malliopoulou V, et al. Increased resistance to activated protein C and factor V Leiden in recurrent abortions. Review of other hypercoagu- lability factors. Eur J Contracept Reprod Health Care 1999;4(3):135-144.
  24. Ridker PM, Miletich JP, Buring JE, Ariyo AA, Price DT, Manson JE, Hill JA. Factor V Leiden mutation as a risk factor for recurrent pregnancy loss. Ann Intern Med 1998;128(12 Pt 1):1000-1003.
  25. Pabinger I, Nemes L, Rintelen C, Koder S, Lechler E, Loreth RM, Kyrle PA, et al. Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden. Hematol J 2000;1(1):37-41.
  26. Sanson BJ, Friederich PW, Simioni P, Zanardi S, Hils- man MV, Girolami A, ten Cate JW, et al. The risk of abortion and stillbirth in antithrombin-, protein C-, and protein S-deficient women. Thromb Haemost 1996;75(3):387-388.
  27. ten Kate MK, van der Meer J. Protein S deficiency: a clinical perspective. Haemophilia 2008;14(6):1222- 1228.
  28. Goodman CS, Coulam CB, Jeyendran RS, Acosta VA, Roussev R. Which thrombophilic gene mutations are risk factors for recurrent pregnancy loss? Am J Reprod Immunol 2006;56(4):230-236.
  29. Coulam CB, Jeyendran RS, Fishel LA, Roussev R. Mul- tiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscar- riage. Am J Reprod Immunol 2006;55(5):360-368.
  30. Coulam CB, Wallis D, Weinstein J, DasGupta DS, Jey- endran RS. Comparison of thrombophilic gene muta- tions among patients experiencing recurrent miscar- riage and deep vein thrombosis. Am J Reprod Immunol 2008;60(5):426-431.
  31. Fatini C, Gensini F, Battaglini B, Prisco D, Cellai AP, Fedi S, Marcucci R, et al. Angiotensin-converting en- zyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinemia increase first-tri- mester fetal-loss susceptibility. Blood Coagul Fibrinoly- sis 2000;11(7):657-662.
  32. Lissak A, Sharon A, Fruchter O, Kassel A, Sanderovitz J, Abramovici H. Polymorphism for mutation of cyto- sine to thymine at location 677 in the methylenetetra- hydrofolate reductase gene is associated with recurrent early fetal loss. Am J Obstet Gynecol 1999;181(1):126- 130.
  33. Nelen WL, van der Molen EF, Blom HJ, Heil SG, Steegers EA, Eskes TK. Recurrent early pregnancy loss and genetic-related disturbances in folate and homocys- teine metabolism. Br J Hosp Med 1997;58(10):511-513.
  34. Wouters MG, Boers GH, Blom HJ, Trijbels FJ, Thom- as CM, Borm GF, Steegers-Theunissen RP, et al. Hy- perhomocysteinemia: a risk factor in women with un- explained recurrent early pregnancy loss. Fertil Steril 1993;60(5):820-825.
  35. Makino A, Nakanishi T, Sugiura-Ogasawara M, Ozaki Y, Suzumori N, Suzumori K. No association of C677T methylenetetrahydrofolate reductase and an endothelial nitric oxide synthase polymorphism with recurrent preg- nancy loss. Am J Reprod Immunol 2004;52(1):60-66.
  36. Nadir Y, Hoffman R, Brenner B. Association of homo- cysteine, vitamin B12, folic acid, and MTHFR C677T in patients with a thrombotic event or recurrent fetal loss. Ann Hematol 2007;86(1):35-40.
  37. Noble LS, Kutteh WH, Lashey N, Franklin RD, Herrada J. Antiphospholipid antibodies associated with recur- rent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular- weight heparin versus unfractionated heparin. Fertil Steril 2005;83(3):684-690.
  38. Infante-Rivard C, David M, Gauthier R, Rivard GE. Lupus anticoagulants, anticardiolipin antibodies, and fetal loss. A case-control study. N Engl J Med 1991;325(15):1063-1066.
  39. Higashino M, Takakuwa K, Arakawa M, Tamura M, Yasuda M, Tanaka K. Anti-cardiolipin antibody and anti-cardiolipin beta-2-glycoprotein I antibody in pa- tients with recurrent fetal miscarriage. J Perinat Med 1998;26(5):384-389.
  40. Chakrabarti S, Bhunia C, Bhattacharya DK. The prevalence of antiphospholipid antibodies in cases of recurrent pregnancy loss. J Assoc Physicians India 1999;47(5):496-498.
  41. Das I, Vasishta K, Dash S. Study of lupus anticoagulant in pregnant women with recurrent abortion. Aust N Z J Obstet Gynaecol 1991;31(4):323-326.
  42. Asherson RA, Cervera R. 'Primary', 'secondary' and other variants of the antiphospholipid syndrome. Lupus 1994;3(4):293-298.
  43. Ogasawara M, Aoki K, Matsuura E, Sasa H, Yagami Y. Anti beta 2glycoprotein I antibodies and lupus antico- agulant in patients with recurrent pregnancy loss: preva- lence and clinical significance. Lupus 1996;5(6):587- 592.
  44. De Carolis S, Caruso A, Ferrazzani S, Carducci B, De Santis L, Mancuso S. Poor pregnancy outcome and anti- cardiolipin antibodies. Fetal Diagn Ther 1994;9(5):296- 299.
  45. Blumenfeld Z, Weiner Z, Lorber M, Sujov P, Thaler I. Anticardiolipin antibodies in patients with recurrent pregnancy wastage: treatment and uterine blood flow. Obstet Gynecol 1991;78(4):584-589.
  46. Brown HL. Antiphospholipid antibodies and recurrent pregnancy loss. Clin Obstet Gynecol 1991;34(1):17-26.
  47. Carmo-Pereira S, Bertolaccini ML, Escudero-Contreras A, Khamashta MA, Hughes GR. Value of IgA anticar- diolipin and anti-beta2-glycoprotein I antibody testing in patients with pregnancy morbidity. Ann Rheum Dis 2003;62(6):540-543.
  48. Nishiguchi T, Kobayashi T. Antiphospholipid syndrome: characteristics and obstetrical management. Curr Drug Targets 2005;6(5):593-605.
  49. Zammiti W, Mtiraoui N, Kallel C, Mercier E, Almawi WY, Mahjoub T. A case-control study on the association of idiopathic recurrent pregnancy loss with autoantibod- ies against beta2-glycoprotein I and annexin V. Repro- duction 2006;131(4):817-822.
  50. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, et al. International con- statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an inter- national workshop. Arthritis Rheum 1999;42(7):1309- 1311.
  51. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, et al. International consen- sus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4(2):295-306.
  52. Jones DW, MacKie IJ, Gallimore MJ, Winter M. Anti- bodies to factor XII and recurrent fetal loss in patients with the anti-phospholipid syndrome. Br J Haematol 2001;113(2):550-552.
  53. D'Uva M, Strina I, Mollo A, Ranieri A, De Placido G, Di Micco P. Acquired factor XII deficiency in a woman with recurrent pregnancy loss: working on a differential diagnosis in a single case. J Transl Med 2005;3(43.
  54. Dossenbach-Glaninger A, van Trotsenburg M, Kru- gluger W, Dossenbach MR, Oberkanins C, Huber J, Hopmeier P. Elevated coagulation factor VIII and the risk for recurrent early pregnancy loss. Thromb Hae- most 2004;91(4):694-699.
  55. Tal J, Schliamser LM, Leibovitz Z, Ohel G, Attias D. A possible role for activated protein C resistance in pa- tients with first and second trimester pregnancy failure. Hum Reprod 1999;14(6):1624-1627.
  56. Gris JC, Quere I, Monpeyroux F, Mercier E, Ripart- Neveu S, Tailland ML, Hoffet M, et al. Case-control study of the frequency of thrombophilic disorders in couples with late foetal loss and no thrombotic ante- cedent--the Nimes Obstetricians and Haematologists Study5 (NOHA5). Thromb Haemost 1999;81(6):891- 899.
  57. Marquard K, Westphal LM, Milki AA, Lathi RB. Etiol- ogy of recurrent pregnancy loss in women over the age of 35 years. Fertil Steril 2009.